Fennec Pharmaceuticals Inc. (FENC) Ownership

$8.36

$0.17 (-1.99%)
Last update: 04:00 PM EST
Day's range
$8.36
Day's range
$8.65

Fennec Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SOUTHPOINT CAPITAL ADVISORS LP 05/15/2025 4.08 M $24.83 M   0.00% 14.78%
SOLAS CAPITAL MANAGEMENT, LLC 05/15/2025 2.25 M $13.71 M   0.00% 8.25%
ROSALIND ADVISORS, INC. 05/14/2025 1.78 M $10.86 M   41.51% 6.53%
BLACKROCK, INC. 05/02/2025 1.25 M $7.61 M   1.95% 4.53%
VANGUARD GROUP INC 05/09/2025 964.62 K $5.87 M   -0.53% 3.50%
HARBERT FUND ADVISORS, INC. 05/14/2025 466.87 K $2.84 M   0.00% 1.69%
AIGH CAPITAL MANAGEMENT LLC 05/06/2025 361.01 K $2.20 M   100.00% 1.31%
STATE STREET CORP 05/15/2025 338.13 K $2.06 M   -0.47% 1.23%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 311.33 K $1.90 M   2.72% 1.13%
MORGAN STANLEY 05/15/2025 296.61 K $1.81 M   -14.37% 1.08%
LION POINT CAPITAL, LP 05/15/2025 195.70 K $1.19 M   0.00% 0.72%
GENDELL JEFFREY L 05/15/2025 195.22 K $1.19 M   -2.03% 0.71%
NORTHERN TRUST CORP 05/13/2025 138.38 K $842.70 K   1.18% 0.50%
DG CAPITAL MANAGEMENT, LLC 05/14/2025 84.21 K $512.86 K   -92.45% 0.31%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 61.15 K $372.38 K   0.00% 0.22%
BANK OF NEW YORK MELLON CORP 04/29/2025 53.51 K $325.85 K   2.64% 0.19%
HARTFORD FINANCIAL MANAGEMENT INC. 04/21/2025 49.85 K $303.58 K   0.00% 0.18%
GOLDMAN SACHS GROUP INC 06/27/2025 43.22 K $263.21 K   -39.30% 0.16%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 41.01 K $249.78 K   -8.09% 0.15%
RHUMBLINE ADVISERS 05/29/2025 33.36 K $203.18 K   -2.73% 0.12%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 30.26 K $184.27 K   143.39% 0.11%
WEXFORD CAPITAL LP 05/15/2025 26.41 K $160.86 K   0.00% 0.10%
UBS GROUP AG 05/13/2025 26.25 K $159.89 K   69.14% 0.10%
05/12/2025 26.01 K $158.38 K   100.00% 0.09%
BARCLAYS PLC 05/15/2025 24.30 K $148.00 K   -31.88% 0.09%
BANK OF AMERICA CORP /DE/ 05/15/2025 22.41 K $136.45 K   -37.46% 0.08%
STATE OF WISCONSIN INVESTMENT BOARD 05/15/2025 22.00 K $133.98 K   -35.29% 0.08%
SHERBROOKE PARK ADVISERS LLC 05/15/2025 17.88 K $108.88 K   -17.57% 0.06%
CITIGROUP INC 05/12/2025 17.20 K $110.05 K   -7.67% 0.06%
FRANKLIN RESOURCES INC 05/13/2025 15.99 K $97.37 K   0.64% 0.06%
PINNACLE WEALTH PLANNING SERVICES, INC. 05/15/2025 15.42 K $93.90 K   0.20% 0.06%
INTECH INVESTMENT MANAGEMENT LLC 05/20/2025 15.13 K $92.13 K   37.68% 0.05%
JANE STREET GROUP, LLC 05/19/2025 14.72 K $89.63 K   100.00% 0.05%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 05/15/2025 14.07 K $85.66 K   4.64% 0.05%
WELLS FARGO & COMPANY/MN 05/13/2025 13.66 K $83.20 K   3.87% 0.05%
METLIFE INVESTMENT MANAGEMENT, LLC 05/14/2025 12.05 K $73.39 K   -23.12% 0.04%
JPMORGAN CHASE & CO 05/12/2025 11.72 K $71.38 K   8.84% 0.04%
COREBRIDGE FINANCIAL, INC. 05/14/2025 11.66 K $71.03 K   0.09% 0.04%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 10.90 K $66.36 K   100.00% 0.04%
NEW YORK STATE COMMON RETIREMENT FUND 05/01/2025 9.75 K $59.00 K   0.00% 0.04%
JONES FINANCIAL COMPANIES LLLP 05/28/2025 8.85 K $57.53 K   27.34% 0.03%
05/09/2025 6.25 K $38.06 K   0.00% 0.02%
ROYAL BANK OF CANADA 05/15/2025 2.93 K $18.00 K   -37.20% 0.01%
LEGAL & GENERAL GROUP PLC 05/15/2025 2.45 K $14.96 K   0.00% 0.01%
FMR LLC 05/12/2025 1.84 K $11.21 K   -9.75% 0.01%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 05/15/2025 1.70 K $10.34 K   0.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 05/15/2025 1.70 K $10.32 K   -22.81% 0.01%
CIBC PRIVATE WEALTH GROUP, LLC 05/14/2025 1.57 K $7.84 K   0.00% 0.01%
AMERITAS INVESTMENT PARTNERS, INC. 05/12/2025 1.50 K $9.13 K   0.00% 0.01%
STATE OF WYOMING 05/14/2025 1.31 K $8.00 K   15.36% 0.00%

Fennec Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 32 institutional investors and hedge funds held shares of Fennec Pharmaceuticals Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 1.23 M

AIGH Capital Management LLC: 452,400

CIBC Private Wealth Group, LLC: 1,565

Private Wealth Management Group, LLC: 247

GAMMA Investing LLC: 113

WEXFORD CAPITAL LP: 0

48.55% of Fennec Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 9.13 M shares in the last 24 months. This purchase volume represents approximately $76.32 M in transactions.